Phase Ib evaluation of a self-adjuvanted protamine formulated mRNA-based active cancer immunotherapy, BI1361849(CV9202), combined with local radiation treatment in patients with stage IVnon-small cell lung cancer - Papachristofilou, Alexandros; Hipp, Madeleine M.; Klinkhardt, Ute; Früh, Martin; Sebastian, Martin; Weiss, Christian; Pless, Miklos; Cathomas, Richard Liberat; Hilbe, Wolfgang; Pall, Georg; Wehler, Thomas; Alt, Jürgen; et al. (Journal for ImmunoTherapy of Cancer, 2019)